These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
223 related items for PubMed ID: 3276782
1. Recombinant human tumor necrosis factors alpha and beta stimulate fibroblasts to produce hemopoietic growth factors in vitro. Zucali JR, Broxmeyer HE, Gross MA, Dinarello CA. J Immunol; 1988 Feb 01; 140(3):840-4. PubMed ID: 3276782 [Abstract] [Full Text] [Related]
2. The suppressive influences of human tumor necrosis factors on bone marrow hematopoietic progenitor cells from normal donors and patients with leukemia: synergism of tumor necrosis factor and interferon-gamma. Broxmeyer HE, Williams DE, Lu L, Cooper S, Anderson SL, Beyer GS, Hoffman R, Rubin BY. J Immunol; 1986 Jun 15; 136(12):4487-95. PubMed ID: 3086433 [Abstract] [Full Text] [Related]
3. The role of protein kinase C in interleukin 1 and tumor necrosis factor alpha induction of fibroblasts to produce and release granulocyte-macrophage colony-stimulating activity. Zucali JR, Morse C, Dinarello CA. Exp Hematol; 1990 Sep 15; 18(8):888-92. PubMed ID: 2167234 [Abstract] [Full Text] [Related]
4. Comparative analysis of the influences of human gamma, alpha and beta interferons on human multipotential (CFU-GEMM), erythroid (BFU-E) and granulocyte-macrophage (CFU-GM) progenitor cells. Broxmeyer HE, Lu L, Platzer E, Feit C, Juliano L, Rubin BY. J Immunol; 1983 Sep 15; 131(3):1300-5. PubMed ID: 6193183 [Abstract] [Full Text] [Related]
5. Effects of recombinant human tumor necrosis factor on highly enriched hematopoietic progenitor cell populations from normal human bone marrow and peripheral blood and bone marrow from patients with chronic myeloid leukemia. Wisniewski D, Strife A, Atzpodien J, Clarkson BD. Cancer Res; 1987 Sep 15; 47(18):4788-94. PubMed ID: 3040231 [Abstract] [Full Text] [Related]
6. Synergistic effects of purified recombinant human and murine B cell growth factor-1/IL-4 on colony formation in vitro by hematopoietic progenitor cells. Multiple actions. Broxmeyer HE, Lu L, Cooper S, Tushinski R, Mochizuki D, Rubin BY, Gillis S, Williams DE. J Immunol; 1988 Dec 01; 141(11):3852-62. PubMed ID: 3053902 [Abstract] [Full Text] [Related]
7. Opposite effect of tumor necrosis factor alpha on granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor-dependent growth of normal and leukemic hemopoietic progenitors. Piacibello W, Sanavio F, Severino A, Morelli S, Vaira AM, Stacchini A, Aglietta M. Cancer Res; 1990 Aug 15; 50(16):5065-71. PubMed ID: 1696165 [Abstract] [Full Text] [Related]
8. Production of colony-stimulating factor(s) for granulocyte-macrophage and multipotential (granulocyte/erythroid/megakaryocyte/macrophage) hematopoietic progenitor cells (CFU-GEMM) by clonal lines of human IL-2-dependent T-lymphocytes. Greenberger JS, Krensky AM, Messner H, Burakoff SJ, Wandl U, Sakakeeny MA. Exp Hematol; 1984 Oct 15; 12(9):720-7. PubMed ID: 6333354 [Abstract] [Full Text] [Related]
9. Influence of IL-1 alpha and -1 beta on the survival of human bone marrow cells responding to hematopoietic colony-stimulating factors. Hangoc G, Williams DE, Falkenburg JH, Broxmeyer HE. J Immunol; 1989 Jun 15; 142(12):4329-34. PubMed ID: 2656864 [Abstract] [Full Text] [Related]
10. Effect of stem cell factor (c-kit ligand), granulocyte-macrophage colony stimulating factor and interleukin 3 on hematopoietic progenitors in human long-term bone marrow cultures. Lemoli RM, Gulati SC. Stem Cells; 1993 Sep 15; 11(5):435-44. PubMed ID: 7694721 [Abstract] [Full Text] [Related]
11. In vitro sensitivity of post-bone marrow transplantation CFU-GM and BFU-E to TNF-alpha and IFN-gamma. Papadakis V, Ferguson KF, Heller G, Kernan NA. Exp Hematol; 1995 Dec 15; 23(14):1422-30. PubMed ID: 8542927 [Abstract] [Full Text] [Related]
12. Modulation of the activity of a human granulocyte-macrophage colony-stimulating factor/interleukin-3 fusion protein (pIXY 321) by the macrocyclic lactone protein kinase C activator bryostatin 1. McCrady CW, Li F, Pettit GR, Grant S. Exp Hematol; 1993 Jul 15; 21(7):893-900. PubMed ID: 7686503 [Abstract] [Full Text] [Related]
13. Suppressive biological activity of a synthetic pentapeptide on highly enriched human and murine marrow hematopoietic progenitors: synergism with recombinant human tumor necrosis factor-alpha and interferon-gamma. Lu L, Foa P, Chillemi F, Shen RN, Lin ZH, Carow C, Broxmeyer HE. Exp Hematol; 1989 Oct 15; 17(9):935-41. PubMed ID: 2506072 [Abstract] [Full Text] [Related]
14. Responsiveness of highly enriched CFU-GM subpopulations from bone marrow, peripheral blood, and cord blood to hemopoietic growth inhibitors. Piacibello W, Ferrero D, Sanavio F, Badoni R, Stacchini A, Severino A, Aglietta M. Exp Hematol; 1991 Dec 15; 19(11):1084-9. PubMed ID: 1752317 [Abstract] [Full Text] [Related]
15. Transforming growth factor-beta 1 enhances the suppression of human hematopoiesis by tumor necrosis factor-alpha or recombinant interferon-alpha. Sing GK, Keller JR, Ellingsworth LR, Ruscetti FW. J Cell Biochem; 1989 Feb 15; 39(2):107-15. PubMed ID: 2715197 [Abstract] [Full Text] [Related]
16. Interleukin-11 stimulates the proliferation of human hematopoietic CD34+ and CD34+CD33-DR- cells and synergizes with stem cell factor, interleukin-3, and granulocyte-macrophage colony-stimulating factor. Lemoli RM, Fogli M, Fortuna A, Motta MR, Rizzi S, Benini C, Tura S. Exp Hematol; 1993 Dec 15; 21(13):1668-72. PubMed ID: 7694867 [Abstract] [Full Text] [Related]
17. Comparative analysis of the human macrophage inflammatory protein family of cytokines (chemokines) on proliferation of human myeloid progenitor cells. Interacting effects involving suppression, synergistic suppression, and blocking of suppression. Broxmeyer HE, Sherry B, Cooper S, Lu L, Maze R, Beckmann MP, Cerami A, Ralph P. J Immunol; 1993 Apr 15; 150(8 Pt 1):3448-58. PubMed ID: 7682242 [Abstract] [Full Text] [Related]
18. Interleukin 1 and poly(rI).poly(rC) induce production of granulocyte CSF, macrophage CSF, and granulocyte-macrophage CSF by human endothelial cells. Fibbe WE, Daha MR, Hiemstra PS, Duinkerken N, Lurvink E, Ralph P, Altrock BW, Kaushansky K, Willemze R, Falkenburg JH. Exp Hematol; 1989 Mar 15; 17(3):229-34. PubMed ID: 2465167 [Abstract] [Full Text] [Related]
19. Growth characteristics of marrow hematopoietic progenitor/precursor cells from patients on a phase I clinical trial with purified recombinant human granulocyte-macrophage colony-stimulating factor. Broxmeyer HE, Cooper S, Williams DE, Hangoc G, Gutterman JU, Vadhan-Raj S. Exp Hematol; 1988 Aug 15; 16(7):594-602. PubMed ID: 3260558 [Abstract] [Full Text] [Related]
20. Tumor necrosis factor-alpha and hematopoietic progenitors: effects of tumor necrosis factor on the growth of erythroid progenitors CFU-E and BFU-E and the hematopoietic cell lines K562, HL60, and HEL cells. Roodman GD, Bird A, Hutzler D, Montgomery W. Exp Hematol; 1987 Oct 15; 15(9):928-35. PubMed ID: 2820776 [Abstract] [Full Text] [Related] Page: [Next] [New Search]